Genomatica Completes $90M Equity Financing

genomaticaGenomatica, a San Diego, CA-based biotechnology company, raised $90m in equity funding.

Participants included new lead investor Casdin Capital, returning investor Viking Global Investors and organism engineering partner Ginkgo Bioworks.

The company intends to use the funds to accelerates expansion of its product lines and strengthen the partnership with Ginkgo Bioworks.

Genomatica develops bio-based process technologies that enable the production of widely-used chemicals, from alternative feedstocks. The company has commercialized two commercial processes.
The first, for biobased 1,4-butanediol (BDO) is an ingredient in the production of millions of biodegradable, compostable plastic bags, coffee capsules and food packaging.
The second process, for biobased Brontide™ butylene glycol, is being used to make a range of more natural cosmetic and personal care products.
Genomatica is also advancing a new process to make 100% biobased nylon-6 for clothing and carpets.



Join the discussion